Stocks and InvestingStocks and Investing
Mon, January 10, 2022
Sun, January 9, 2022
Fri, January 7, 2022
Thu, January 6, 2022

Yaron Werber Initiated (ASND) at Hold and Held Target at $136 on, Jan 6th, 2022


Published on 2024-10-27 19:09:38 - WOPRAI, Yaron Werber
  Print publication without navigation


Yaron Werber of Cowen & Co., Initiated "Ascendis Pharma A/S" (ASND) at Hold and Held Target at $136 on, Jan 6th, 2022.

Yaron has made no other calls on ASND in the last 4 months.



There are 4 other peers that have a rating on ASND. Out of the 4 peers that are also analyzing ASND, 1 agrees with Yaron's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Increased Target to $169 on, Wednesday, October 20th, 2021


These are the ratings of the 3 analyists that currently disagree with Yaron


  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $176 on, Wednesday, December 8th, 2021
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $190 on, Monday, November 15th, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $179 on, Thursday, November 11th, 2021